Clinical Trials · NCT06820281
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Victor Chang Cardiac Research Institute
- Enrollment
- 44
- Start date
- Jul 2026
- Locations
- 1 site, Australia
- Primary endpoint
- Whole-body insulin sensitivity